Concentration-effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side-effects in healthy subjects.

Source:http://linkedlifedata.com/resource/pubmed/id/11421999

Download in:

View as

General Info

PMID
11421999